Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cáceres EL"'
Autor:
Carme Lopez Matheu CL (AUTHOR), Enrique Limon Cáceres EL (AUTHOR), Isabel Oto Clavero IO (AUTHOR), Fernández JC (AUTHOR), de Desa JEE (AUTHOR), de Luaces VL (AUTHOR), Climent BP (AUTHOR), Torrells JMR (AUTHOR)
Publikováno v:
Cultura de los Cuidados. Mar2009, Vol. 13 Issue 25, p81-87. 7p.
Autor:
Andalib S; Research Unit of Neurology, Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.; Department of Neurology, Odense University Hospital, Odense, Denmark., Divani AA; Department of Neurology, School of Medicine, University of New Mexico, Albuquerque, NM, 87131, USA. adivani@gmail.com., Ayata C; Neurovascular Research Unit, Department of Radiology and Stroke Service, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA., Baig S; Department of Neuroscience, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK., Arsava EM; Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Topcuoglu MA; Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Cáceres EL; Department of Critical Care, Clínica de La Universidad de La Sabana, Chía, Colombia., Parikh V; Department of Psychology and Neuroscience, Temple University, Philadelphia, PA, USA., Desai MJ; Department of Neurology, School of Medicine, University of New Mexico, Albuquerque, NM, 87131, USA., Majid A; Department of Neuroscience, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK., Girolami S; Neurological Service, SS Annunziata Hospital, Sulmona, L'Aquila, Italy., Di Napoli M; Neurological Service, SS Annunziata Hospital, Sulmona, L'Aquila, Italy.
Publikováno v:
Current neurology and neuroscience reports [Curr Neurol Neurosci Rep] 2023 Dec; Vol. 23 (12), pp. 947-962. Date of Electronic Publication: 2023 Nov 27.
Autor:
Ospina-Tascón GA; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia.; Translational Medicine Laboratory in Critical Care (TransLab-CCM), Universidad Icesi, Cali, Colombia., Calderón-Tapia LE; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia.; Translational Medicine Laboratory in Critical Care (TransLab-CCM), Universidad Icesi, Cali, Colombia., García AF; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia.; Translational Medicine Laboratory in Critical Care (TransLab-CCM), Universidad Icesi, Cali, Colombia., Zarama V; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia., Gómez-Álvarez F; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia., Álvarez-Saa T; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia., Pardo-Otálvaro S; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia., Bautista-Rincón DF; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia., Vargas MP; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia., Aldana-Díaz JL; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia.; Translational Medicine Laboratory in Critical Care (TransLab-CCM), Universidad Icesi, Cali, Colombia., Marulanda Á; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia.; Translational Medicine Laboratory in Critical Care (TransLab-CCM), Universidad Icesi, Cali, Colombia., Gutiérrez A; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia., Varón J; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia., Gómez M; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia., Ochoa ME; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia., Escobar E; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia.; Translational Medicine Laboratory in Critical Care (TransLab-CCM), Universidad Icesi, Cali, Colombia., Umaña M; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia., Díez J; Department of Intensive Care, Fundación Valle del Lili, Cali, Colombia., Tobón GJ; Department of Pathology and Laboratory Medicine, Fundación Valle del Lili-Universidad Icesi, Cali, Colombia., Albornoz LL; Department of Pathology and Laboratory Medicine, Fundación Valle del Lili-Universidad Icesi, Cali, Colombia., Celemín Flórez CA; Departamento de Cuidado Crítico, SubRed Centro-Oriente, Universidad del Bosque, Bogotá, Colombia., Ruiz GO; Departamento de Cuidado Crítico, SubRed Centro-Oriente, Universidad del Bosque, Bogotá, Colombia., Cáceres EL; Department of Critical Care, Clínica de la Universidad de La Sabana, Chía, Colombia., Reyes LF; Department of Critical Care, Clínica de la Universidad de La Sabana, Chía, Colombia.; Department of Infectious Diseases, Universidad de La Sabana, Chía, Colombia., Damiani LP; HCor Research Institute-Hospital do Coração, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Cavalcanti AB; HCor Research Institute-Hospital do Coração, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Publikováno v:
JAMA [JAMA] 2021 Dec 07; Vol. 326 (21), pp. 2161-2171.
Adding Stochastic Negative Examples into Machine Learning Improves Molecular Bioactivity Prediction.
Autor:
Cáceres EL; Department of Pharmaceutical Chemistry, Department of Bioengineering and Therapeutic Sciences, Bakar Computational Health Sciences Institute, Kavli Institute for Fundamental Neuroscience, Institute for Neurodegenerative Diseases, University of California, San Francisco, 675 Nelson Rising Ln NS 416A, San Francisco, California 94143, United States., Mew NC; Department of Pharmaceutical Chemistry, Department of Bioengineering and Therapeutic Sciences, Bakar Computational Health Sciences Institute, Kavli Institute for Fundamental Neuroscience, Institute for Neurodegenerative Diseases, University of California, San Francisco, 675 Nelson Rising Ln NS 416A, San Francisco, California 94143, United States., Keiser MJ; Department of Pharmaceutical Chemistry, Department of Bioengineering and Therapeutic Sciences, Bakar Computational Health Sciences Institute, Kavli Institute for Fundamental Neuroscience, Institute for Neurodegenerative Diseases, University of California, San Francisco, 675 Nelson Rising Ln NS 416A, San Francisco, California 94143, United States.
Publikováno v:
Journal of chemical information and modeling [J Chem Inf Model] 2020 Dec 28; Vol. 60 (12), pp. 5957-5970. Date of Electronic Publication: 2020 Nov 27.
Autor:
Cáceres EL; Computational & Structural Chemistry, Merck & Co., Inc., South San Francisco, CA 94080, USA.; Department of Pharmaceutical Chemistry; Graduate Program in Biological & Medical Informatics; Department of Bioengineering & Therapeutic Sciences; Bakar Computational Health Sciences Institute; Kavli Institute for Fundamental Neuroscience; Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA 94143, USA., Tudor M; Computational & Structural Chemistry, Merck & Co., Inc., West Point, PA 19486, USA., Cheng AC; Computational & Structural Chemistry, Merck & Co., Inc., South San Francisco, CA 94080, USA.
Publikováno v:
Future medicinal chemistry [Future Med Chem] 2020 Nov; Vol. 12 (22), pp. 1995-1999. Date of Electronic Publication: 2020 Oct 30.
Autor:
Axen SD; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco , 675 Nelson Rising Lane NS 416A, San Francisco, California 94143, United States., Huang XP; Department of Pharmacology, University of North Carolina School of Medicine , Chapel Hill, North Carolina 27599, United States.; National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP), University of North Carolina , Chapel Hill, North Carolina 27599, United States., Cáceres EL; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco , 675 Nelson Rising Lane NS 416A, San Francisco, California 94143, United States.; Department of Pharmaceutical Chemistry, Institute for Neurodegenerative Diseases, and Institute for Computational Health Sciences, University of California, San Francisco , 675 Nelson Rising Lane NS 416A, San Francisco, California 94143, United States., Gendelev L; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco , 675 Nelson Rising Lane NS 416A, San Francisco, California 94143, United States.; Department of Pharmaceutical Chemistry, Institute for Neurodegenerative Diseases, and Institute for Computational Health Sciences, University of California, San Francisco , 675 Nelson Rising Lane NS 416A, San Francisco, California 94143, United States., Roth BL; Department of Pharmacology, University of North Carolina School of Medicine , Chapel Hill, North Carolina 27599, United States.; National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP), University of North Carolina , Chapel Hill, North Carolina 27599, United States.; Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina 27599, United States., Keiser MJ; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco , 675 Nelson Rising Lane NS 416A, San Francisco, California 94143, United States.; Department of Pharmaceutical Chemistry, Institute for Neurodegenerative Diseases, and Institute for Computational Health Sciences, University of California, San Francisco , 675 Nelson Rising Lane NS 416A, San Francisco, California 94143, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2017 Sep 14; Vol. 60 (17), pp. 7393-7409. Date of Electronic Publication: 2017 Aug 08.